Pegamotecan (PEG-camptothecin) is a topoisomerase I (TOP1) inhibitor with anticancer activity, and it is used in the treatment of esophageal, non-small cell lung and pancreatic cancers.
Molecular Weight:
980.984
Purity:
96.40%
CAS Number:
[581079-18-7]
Formula:
C52H48N6O14
Target:
Topoisomerase
T24610
* VAT and and shipping costs not included. Errors and price changes excepted